S&P 500, Dow gain as upbeat retail sales offset recession fears
By Stephen Culp NEW YORK (Reuters) - The S&P 500 and the Dow gained ground in a late rally on Thursday as upbeat retail sales data offset recessionary fears amid the simmering U.S.-China trade tensions. Wall Street zig-zagged from red to black and back much of the day as investors juggled mixed messages of a strong consumer and dropping U.S. Treasury yields.
By Stephen Culp
NEW YORK (Reuters) - The S&P 500 and the Dow gained ground in a late rally on Thursday as upbeat retail sales data offset recessionary fears amid the simmering U.S.-China trade tensions.
Wall Street zig-zagged from red to black and back much of the day as investors juggled mixed messages of a strong consumer and dropping U.S. Treasury yields.
The Nasdaq closed lower, weighed by a plunge in the shares of Cisco Systems Inc
"You've an environment where we're digesting the move down in interest rates and the yield curve yesterday," said Darrell Cronk, chief investment officer for Wells Fargo Wealth and Investment Management in New York. "Volume is lighter today. You're not getting outsized movements one way or the other."
Those concerns were further eased when retail sales data surpassed analyst expectations. Consumers, who account for about 70% of the U.S. economy, stepped up their spending across the board in July, according to the Commerce Department.
"One thing the market took solace in today is better U.S. economic data," Cronk added. "That helped to calm some of the fears from yesterday."
Other economic data was less sanguine. Manufacturing output shrank more than expected in July, according to the U.S. Federal Reserve, and new claims for unemployment benefits came in above economist forecasts.
Belligerent rhetoric kept U.S.-China trade tensions at a low boil, as China vowed it would counter the last round of tariffs on Chinese imports and called on the United States to meet it halfway, while U.S. President Donald Trump said in an interview any deal must be made "on our terms."
The prolonged escalation of the trade war between the world's two largest economies and the economic fallout have vexed global markets for months and have begun to drag on some companies' top lines.
Impending U.S. tariffs weighed on Cisco Systems, which plunged 8.6% after reporting a 25% drop in China sales and set sales and revenue forecasts well below analyst estimates.
Trade tensions also sent the U.S. 30-year Treasury yield to a record low and the benchmark 10-year yield to a three-year trough.
The Dow Jones Industrial Average <.DJI> rose 99.97 points, or 0.39%, to 25,579.39, the S&P 500 <.SPX> gained 7 points, or 0.25%, to 2,847.6, and the Nasdaq Composite <.IXIC> dropped 7.32 points, or 0.09%, to 7,766.62.
Of the 11 major sectors of the S&P 500, six closed the day in positive territory, with consumer staples <.SPLRCS> enjoying the largest percentage gain.
Shares of JC Penney Co Inc
General Electric Co shares dropped 11.3% on the heels of a report from whistleblower Harry Markopolos accusing the conglomerate of hiding $38.1 billion in potential losses and claiming its cash situation was far worse than disclosed.
Advancing issues outnumbered declining ones on the NYSE by a 1.08-to-1 ratio; on Nasdaq, a 1.37-to-1 ratio favoured decliners.
The S&P 500 posted 14 new 52-week highs and 59 new lows; the Nasdaq Composite recorded 23 new highs and 282 new lows.
Volume on U.S. exchanges was 7.72 billion shares, compared with the 7.53 billion average over the last 20 trading days.
(Reporting by Stephen Culp; additional reporting by Sinead Carew; Editing by Leslie Adler)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
(Reuters) - Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter. A deal for Immunomedics, which last month reported positive data from a late-stage study for its breast-cancer drug, could be announced Monday if not sooner, the Journal said https://www.wsj.com/articles/gilead-nears-deal-to-buy-immunomedics-for-more-than-20-billion-11599936777?mod=hp_lead_pos2. Gilead and Immunomedics did not respond immediately to emailed requests from Reuters for comment
SHANGHAI (Reuters) - China banned pork imports from Germany on Saturday after it confirmed its first case of African swine fever last week, in a move set to hit German producers and push up global prices as China's meat supplies tighten. China's ban on imports from its third largest supplier comes as the world's top meat buyer deals with an unprecedented pork shortage after its own epidemic of the deadly hog disease. The ban on Germany, which has supplied about 14% of China's pork imports so far this year, will push up demand for meat from other major suppliers like the United States and Spain, boosting global prices.
CAIRO (Reuters) - Libyan commander Khalifa Haftar has committed to ending a months-long blockade of oil facilities, the U.S.